Browse the evidence

Strategic ingestion of high-protein dairy milk augmented lean mass, strength, power, and altered serum concentrations of skeletal muscle regulatory markers.

Implementing high-protein dairy milk in post-exercise and pre-sleep nutrition can enhance training outcomes.

Individualized FATmax training reduced body fat% in older women with type 2 diabetes (p<0.001).

Practitioners can consider FATmax training as an effective method for reducing body fat in older women with type 2 diabetes.

Individualized FATmax training improved insulin resistance in older women with type 2 diabetes (p<0.001).

FATmax training may be recommended to improve insulin sensitivity in this population.

Metabolic bariatric surgery (MBS) was associated with greater total weight loss (mean 28.3%) compared to GLP-1 receptor agonists (mean 10.3%) in patients with class II and III obesity.

MBS may be a more effective option for significant weight loss in patients with higher obesity classes.

Carbohydrate restriction leads to weight loss and improved glycaemic status in obese and diabetic subjects.

Implementing carbohydrate restriction can be an effective strategy for weight loss and improving blood sugar levels in targeted populations.

A Mediterranean diet should serve as a basis that can be restructured into other kinds of diets for NAFLD patients.

Practitioners should consider using a Mediterranean diet as a flexible foundation for dietary recommendations for NAFLD patients.

Dietary composition is important for long-term health outcomes in NAFLD patients.

Practitioners should prioritize healthy dietary compositions to ensure long-term safety and efficacy for NAFLD patients.

The intervention group achieved significantly higher protein intake at 26–28 weeks and 36–38 weeks gestation.

Practitioners should focus on increasing protein intake in pregnant women through structured dietary interventions.

Both moderate-load and high-load resistance training resulted in significant increases in lean body mass (1.5 ± 0.83 kg) and lean dry mass (1.32 ± 0.62 kg).

Both training methods are effective for increasing muscle mass in untrained young women.

Both training groups experienced significant decreases in percent body fat (1.3 ± 1.3%).

Both training methods can effectively reduce body fat in untrained young women.

Both moderate-load and high-load training improved strength and power, as evidenced by increases in vertical jump (2.9 ± 3.2 cm) and back squat one repetition maximum (22.5 ± 8.1 kg).

Both training methods are effective for enhancing strength and power in untrained young women.

The multidomain lifestyle intervention (ILI) resulted in a 9% lower increase in multimorbidity index scores compared to diabetes support and education (DSE) over 8 years.

Implementing a multidomain lifestyle intervention may help reduce the progression of multimorbidity in at-risk individuals.

HIIT increased left ventricular stroke volume (LVSV) by 3 months (P = 0.02).

HIIT can enhance stroke volume during exercise in individuals with type 2 diabetes.

Intensified training increased MyoPS and SarcPS above the washout phase with greater increases observed with LA than CP.

Supplementing with LA during intensified training may enhance muscle protein synthesis more than collagen.

Protein synthesis was enhanced to a greater extent when trained participants consumed LA compared with CP during intensified aerobic training.

Endurance athletes should consider LA over collagen for better training adaptations.

The percentage of weight loss as fat-free mass (%FFML) using GLP-1RA-based agents was between 20% and 40%.

Practitioners can expect that GLP-1RA treatments may lead to significant fat-free mass loss.

AOMs have established efficacy and effectiveness for weight loss even beyond 52 weeks.

Practitioners can consider AOMs as effective long-term options for weight management.

Clinical data supporting the use of various FDA-approved medications for weight loss are presented.

Practitioners can rely on clinical data when prescribing FDA-approved weight loss medications.

Medication options are available to treat obesity, which can help reduce appetite and/or reduce caloric intake.

Practitioners can consider pharmacological treatments to assist patients in managing obesity.

GLP-1 receptor agonists have been successfully used in the treatment of obesity and type 2 diabetes.

GLP-1 receptor agonists can be considered as a treatment option for patients with obesity and T2DM.

For trials with a mean BMI ≥35, LDL cholesterol decreased by 7 mg/dL on a low-carbohydrate diet.

Practitioners should note that low-carbohydrate diets may lower LDL cholesterol in individuals with high BMI.

High total protein intake is associated with low CVD morbidity (RR 0.88, 95% CI 0.82-0.94).

Encouraging higher protein intake may reduce the risk of cardiovascular disease.

The treatment with GLP-1 RA resulted in a reduction in the risk of any cardiovascular event with a relative risk of 0.81.

The relative risk indicates a significant benefit of GLP-1 RA in reducing cardiovascular events.

All training protocols significantly increased one repetition maximum (1RM) values post-training, with no significant differences between protocols.

Practitioners can expect similar strength gains across different rest intervals when volume is equalized.